Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells
Author
Aras, SahraÖzdemir, Beril Su
Arısan, Elif Damla
Rencüzoğulları, Özge
Özfiliz Kılbaş, Pelin
Obakan Yerlikaya, Pınar
Çoker Gürkan, Ajda
Palavan Ünsal, Zeynep Narçın
Type
Date
2017-08-30Language
en_USMetadata
Show full item recordCollections
- Makaleler / Articles [140]
- WoS Publications [1016]